Dimethylazanide;N-[[4-(2-ethoxyethyl)morpholin-2-yl]methyl]-3-methylbut-1-en-2-amine;tungsten(2+)
C16H33N3O2W — CID 156795287
Data last refreshed: (MolForge compound catalog, from PubChem)
About Dimethylazanide;N-[[4-(2-ethoxyethyl)morpholin-2-yl]methyl]-3-methylbut-1-en-2-amine;tungsten(2+)
Dimethylazanide;N-[[4-(2-ethoxyethyl)morpholin-2-yl]methyl]-3-methylbut-1-en-2-amine;tungsten(2+) (PubChem CID 156795287) has the molecular formula C16H33N3O2W and a molecular weight of 483.30 g/mol. Its IUPAC name is dimethylazanide;N-[[4-(2-ethoxyethyl)morpholin-2-yl]methyl]-3-methylbut-1-en-2-amine;tungsten(2+).
Molecular Properties
| Compound Name | Dimethylazanide;N-[[4-(2-ethoxyethyl)morpholin-2-yl]methyl]-3-methylbut-1-en-2-amine;tungsten(2+) |
|---|---|
| PubChem CID | 156795287 |
| Molecular Formula | C16H33N3O2W |
| Molecular Weight | 483.30 g/mol |
| Exact Mass | 483.21 |
| IUPAC Name | dimethylazanide;N-[[4-(2-ethoxyethyl)morpholin-2-yl]methyl]-3-methylbut-1-en-2-amine;tungsten(2+) |
| SMILES | C=C(NCC1CN(CCOC[CH2-])CCO1)C(C)C.C[N-]C.[W+2] |
| InChI | InChI=1S/C14H27N2O2.C2H6N.W/c1-5-17-8-6-16-7-9-18-14(11-16)10-15-13(4)12(2)3;1-3-2;/h12,14-15H,1,4-11H2,2-3H3;1-2H3;/q2*-1;+2 |
| InChIKey | ORJHKZCWVSBUKE-UHFFFAOYSA-N |
| XLogP | 1.91 |
| TPSA | 47.83 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 22 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 483.30 |
| LogP ≤ 5 | 1.91 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156795287 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.